LOS ANGELES, Nov 13 (Reuters) - Genentech Inc. (DNA.N: Quote, Profile, Research) and Biogen Idec Inc.'s (BIIB.O: Quote, Profile, Research) cancer drug Rituxan improved symptoms of rheumatoid arthritis in patients not helped by drugs designed to block an inflammation-causing protein, researchers said on Sunday.
